 Arabinofuranosyluracil
"Arabinofuranosyluracil" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pyrimidine nucleoside formed in the body by the deamination of CYTARABINE.
| Descriptor ID |
D001086
|
| MeSH Number(s) |
D03.383.742.680.852.150 D13.570.065.090 D13.570.685.852.150
|
| Concept/Terms |
Arabinofuranosyluracil- Arabinofuranosyluracil
- Ara-U
- Ara U
- Uracil Arabinoside
- Arabinoside, Uracil
- Arauridine
- Sponguridine
- Uracil Arabinofuranoside
- Arabinofuranoside, Uracil
- 1-beta-D-Arabinofuranosyl Uracil
- 1 beta D Arabinofuranosyl Uracil
- Uracil, 1-beta-D-Arabinofuranosyl
- Arabinosyluracil
|
Below are MeSH descriptors whose meaning is more general than "Arabinofuranosyluracil".
Below are MeSH descriptors whose meaning is more specific than "Arabinofuranosyluracil".
This graph shows the total number of publications written about "Arabinofuranosyluracil" by people in this website by year, and whether "Arabinofuranosyluracil" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text, click here.
Below are the most recent publications written about "Arabinofuranosyluracil" by people in Profiles.
-
Jadvar H, Park R, Yap LP, Chen K, Hughes L, Conti P. Effect of Androgen on Normal Biodistribution of [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in Athymic Non-tumor-bearing Male Mice. Anticancer Res. 2017 02; 37(2):475-479.
-
Jadvar H, Yap LP, Park R, Li Z, Chen K, Hughes L, Kouhi A, Conti P. [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations. Mol Imaging. 2012 Sep-Oct; 11(5):426-32.
-
Chen K, Li Z, Conti PS. Microwave-assisted one-pot radiosynthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-?-d-arabinofuranosyluracil ([18F]-FMAU). Nucl Med Biol. 2012 Oct; 39(7):1019-25.
-
Cai H, Li Z, Conti PS. The improved syntheses of 5-substituted 2'-[18F]fluoro-2'-deoxy-arabinofuranosyluracil derivatives ([18F]FAU, [18F]FEAU, [18F]FFAU, [18F]FCAU, [18F]FBAU and [18F]FIAU) using a multistep one-pot strategy. Nucl Med Biol. 2011 Jul; 38(5):659-66.
-
Li Z, Cai H, Conti PS. Improved synthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-?-D-arabinofuranosyluracil ([18F]FMAU). Curr Radiopharm. 2011 Jan; 4(1):24-30.
-
Li Z, Cai H, Conti PS. Automated synthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-?-D-arabinofuranosyluracil ([18F]-FMAU) using a one reactor radiosynthesis module. Nucl Med Biol. 2011 Feb; 38(2):201-6.
-
Conti PS, Bading JR, Mouton PP, Links JM, Alauddin MM, Fissekis JD, Ravert HT, Hilton J, Wong DF, Anderson JH. In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PET. Nucl Med Biol. 2008 Jan; 35(1):131-41.
-
Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. In vivo evaluation of 2'-deoxy-2'-[(18)F]fluoro-5-iodo-1-beta-D-arabinofuranosyluracil ([18F]FIAU) and 2'-deoxy-2'-[18F]fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil ([18F]FEAU) as markers for suicide gene expression. Eur J Nucl Med Mol Imaging. 2007 Jun; 34(6):822-9.
-
Alauddin MM, Shahinian A, Park R, Tohme M, Fissekis JD, Conti PS. Synthesis and evaluation of 2'-deoxy-2'-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression. J Nucl Med. 2004 Dec; 45(12):2063-9.
-
Bading JR, Shahinian AH, Vail A, Bathija P, Koszalka GW, Koda RT, Alauddin MM, Fissekis JD, Conti PS. Pharmacokinetics of the thymidine analog 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats. Nucl Med Biol. 2004 May; 31(4):407-18.
|
Similar Concepts
![expand description]()
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|